Abstract
This study was designed to determine whether both enantiomers of chloroquine inhibit histamine N-methyltransferase. The mean estimates of IC50 for the d- and l-enantiomers of chloroquine were 4.9 and 17.8 μM (liver), respectively and 6.9 and 21.6 μM (brain), respectively. Ki estimates were significantly lower with d- than with l-chloroquine; hence, d-chloroquine interacts with the enzyme more effectively than l-chloroquine. If the adverse effects of chloroquine are due to the inhibition of histamine N-methyltransferase, therapy with the l-enantiomer might have lower toxicity. The residual activity of histamine N-methyltransferase should reflect both the degree of inhibition by chloroquine and the level of enzyme expression. The rate of histamine methylation was measured in 100 human liver samples and its range and fold of variation were 29% and threefold, respectively.
Susceptibility to chloroquine should be greater in subjects with limited expression of histamine N-methyltransferase.
Similar content being viewed by others
References
Frisk-Holmberg M, Berquist Y, Domeijnyberg B, Hellstrom L, Jansson F (1979) Chloroquine serum concentration and side effects: evidence for dose-dependent kinetics. Clin Pharmacol Ther 25: 345–350
Osifo NG (1989) Mechanisms of enhanced pruritogenicity of chloroquine amongs patients with malaria: a review. Afr J Med Sci 18: 121–129
White NJ, Miller KD, Churchill FC, Berry C, Brown J, Williams SB, Greenwood BM (1988) Chloroquine treatment of severe malaria in children. Pharmacogenetics, toxicity and new dosages recommendations. N Engl J Med 319: 1493–1500
Gustafsson LL, Walker O, Alvan G, Beermann B, Estevez F, Gleisner L, Lindstrom B, Sjoqvist F (1983) The disposition of chloroquine in man after single intavenous and oral dose. Br J Clin Pharmacol 15: 471–479
Pacifici GM, Donatelli P, Giuliani L (1992) Histamine N-methyl transferase: inhibition by drugs. Br J Clin Pharmacol 34: 322–327
Fink E, Minet G, Nickel P (1979) Chloroquine-Enantiomere: Wirkung gegen Nagetiermalaria (P. vinkey) und Bindung an DNS. Arzneimittelforschung 29: 163–164
Haberkorn A, Kraft HP, Blaschke G (1979) Antimalarial activity in animals of the optical isomers of chloroquine diphosphate. Trop Med Parasitol 30: 308–312
Fu S, Bjorkman A, Wahlin B, Ofori-Adjei D, Ericsson O, Sjoqvist F (1986) In vitro activity of chloroquine, the two enantiomers of chloroquine, desethylchloroquine and pyronaridine against Plasmodium falciparum. Br J Clin Pharmacol 22: 93–96
Mehler A, Tabor H, Bauer H (1952) The oxidation of histamine to imidazoleacetic acid in vivo. J Biol Chem 197: 475–480
Schayer RW (1952) The metabolism of ring labelled histamine. J Biol Chem 196: 469–475
Beaven MA, Shaff RE (1979) New inhibitors of histamine N-methyl transferase. Biochem Pharmacol 28: 183–188
Tachibana T, Taniguchi S, Fujiwara M, Imamura SS (1986) Regulation of the activity of histamine N-methyltransferase from guinea pig skin by biogenic amines. Exp Mol Path 45: 257–269
Holmstedt B, Hartmut F, Bernard T (1989) Chiral and biological activity. Liss, New York
Blaschke G, Kraft HP, Schwanghart AD (1978) Chloroquine-Enantiomere durch chromatographische Racemattrennung und Synthese. Chem Ber 111: 2732–2734
Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Beaven MA (1982) Factors regulating availability of histamine at tissue receptors. In: Ganellin CR, Parsons ME (eds) Pharmacology of histamine receptors. Wright, Bristol, pp 103–145
Schwartz JC (1977) Histaminergic mechanisms in brain. Annu Rev Pharmacol Toxicol 17: 325–329
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donatelli, P., Marchi, G., Pacifici, G.M. et al. Stereoselective inhibition by chloroquine of histamine N-methyltransferase in the human liver and brain. Eur J Clin Pharmacol 47, 345–349 (1994). https://doi.org/10.1007/BF00191166
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00191166